Is cosyntropin a hormone replacement therapy?

No. Cosyntropin is used for diagnostic testing only—to assess whether your adrenal glands can produce cortisol. It temporarily stimulates cortisol release but doesn't replace it. Patients with adrenal insufficiency who need cortisol replacement receive glucocorticoid medications separately, typically hydrocortisone or prednisone.

How is cosyntropin different from ACTH?

Cosyntropin is a synthetic copy of the first 24 amino acids of natural ACTH. Synthetic cosyntropin is preferred for diagnostic testing because it's standardized, doesn't degrade quickly, and provides consistent, reproducible results—advantages over measuring natural ACTH levels, which fluctuate and can be unstable.

What conditions does the cosyntropin test diagnose?

The cosyntropin stimulation test diagnoses adrenal insufficiency (both primary Addison's disease and secondary insufficiency from pituitary dysfunction). It's also used to evaluate suspected ACTH-secreting tumors and to monitor adrenal function in patients on long-term corticosteroid therapy.

Are there side effects from cosyntropin?

Cosyntropin is well-tolerated. Mild side effects—flushing, dizziness, or injection site reactions—are uncommon. Serious adverse events are rare. Because the test is brief and conducted under medical supervision, safety concerns are minimal.

Can I request a cosyntropin test if I suspect adrenal problems?

You can't order the test yourself, but you can discuss symptoms with your doctor. If they suspect adrenal insufficiency, they may order a cosyntropin stimulation test as part of your diagnostic workup. It's a standard test available at most hospitals and endocrinology clinics.

What is Cosyntropin? FDA-Approved Peptide Definition

Cosyntropin is a synthetic peptide that replicates the action of adrenocorticotropic hormone (ACTH), a naturally occurring hormone in your body. FDA-approved and used clinically since the 1970s, it's primarily prescribed as a diagnostic tool to evaluate how well your adrenal glands function. Unlike many peptides under investigation, cosyntropin has decades of clinical evidence backing its safety and efficacy. It's administered via injection and works by stimulating the adrenal cortex to produce cortisol—a response that doctors measure to diagnose adrenal insufficiency and other endocrine disorders.

Understanding Cosyntropin: Definition and Classification

Cosyntropin is a 24-amino-acid synthetic peptide that mimics the first 24 amino acids of human adrenocorticotropic hormone (ACTH). ACTH is a hormone produced by the pituitary gland that signals your adrenal glands to release cortisol, a critical steroid hormone involved in stress response, metabolism, and immune function.

Because cosyntropin replicates ACTH's structure and function, it can trigger the same adrenal response. The key difference: cosyntropin is synthetic, reproducible, and standardized—making it far more reliable for clinical testing than measuring natural ACTH levels, which fluctuate throughout the day.

How Cosyntropin Works

When injected intravenously or intramuscularly, cosyntropin binds to ACTH receptors on the adrenal cortex. This stimulation prompts the adrenal glands to synthesize and release cortisol into the bloodstream. A clinician then measures cortisol levels at specific time intervals (typically 30 and 60 minutes post-injection) to assess adrenal function.

Research shows that a normal response involves a cortisol rise of at least 18–20 mcg/dL from baseline. If cortisol doesn't rise appropriately, it suggests primary adrenal insufficiency (Addison's disease) or secondary adrenal insufficiency due to pituitary dysfunction.

Regulatory Status and Approval

Cosyntropin carries full FDA approval in the United States, reflecting its long safety record and established clinical utility. The compound has been the subject of over 38 clinical trials, documenting its reliability in diagnostic settings. However, it is not authorized by the EMA in Europe and not approved by Health Canada, meaning availability and regulatory pathways differ by region.

Its FDA approval is based on extensive evidence of diagnostic accuracy and safety. Unlike many peptides that remain under investigation, cosyntropin's indication (adrenal function testing) is well-defined and supported by decades of clinical use.

Primary Clinical Applications

Diagnostic Testing for Adrenal Insufficiency

The primary use of cosyntropin is the cosyntropin stimulation test (also called the ACTH stimulation test). This test is the gold standard for diagnosing primary adrenal insufficiency. Clinical guidelines recommend the low-dose (1 mcg) cosyntropin test as the preferred diagnostic approach due to its superior specificity.

Doctors order this test when patients present with symptoms of adrenal insufficiency, such as:

Chronic fatigue
Unexplained hypotension
Electrolyte abnormalities
Hyperpigmentation (in primary adrenal insufficiency)
Weight loss

Differentiating Types of Adrenal Insufficiency

Cosyntropin testing helps distinguish primary adrenal insufficiency (where the adrenal glands themselves are damaged) from secondary insufficiency (where the pituitary gland fails to produce adequate ACTH). In primary insufficiency, the adrenal glands don't respond to cosyntropin stimulation. In secondary insufficiency, they typically respond normally once stimulated, indicating the problem lies upstream in the pituitary.

Other Clinical Uses

While diagnostic testing is its primary indication, cosyntropin has been studied in additional contexts. Research has explored its potential role in managing septic shock and critical illness, though this remains a specialized application outside routine clinical practice.

How Cosyntropin Differs from Other Peptides

Unlike research compounds such as 5-Amino-1MQ or investigational therapeutics like ARA-290, cosyntropin is not under investigation—it's an established, approved pharmaceutical with a narrow, well-defined clinical purpose. Its peptide structure mirrors a natural hormone, making it essentially a hormone replacement tool for diagnostic use.

Similarly, while some peptides like Abaloparatide are approved for treating bone loss, cosyntropin's approval is specifically for testing, not treatment. This distinction is important: cosyntropin doesn't replace cortisol therapy; it tests whether your body can produce cortisol on demand.

Administration and Practical Considerations

Cosyntropin is administered by injection—either intravenous (IV) or intramuscular (IM)—in a clinical or hospital setting. Doses used for diagnostic testing are typically 250 mcg (standard dose) or 1 mcg (low-dose test). The test procedure is straightforward:

A baseline blood sample is drawn to measure cortisol
Cosyntropin is injected
Additional blood samples are drawn at 30 and 60 minutes
Cortisol levels are measured to assess the adrenal response

The entire procedure takes about 90 minutes and is generally well-tolerated with minimal side effects.

Safety Profile

Cosyntropin has a robust safety record. Adverse events are rare and typically mild, including occasional flushing, dizziness, or local injection site reactions. Because it's used in a controlled diagnostic setting under medical supervision, serious complications are uncommon. Contraindications include allergy to cosyntropin or any component of the formulation.

Why Cosyntropin Remains the Gold Standard

Despite advances in immunoassays and other diagnostic methods, cosyntropin-based stimulation testing remains the clinical standard because:

High specificity: It reliably differentiates primary from secondary adrenal insufficiency
Standardized response: The pharmacology is predictable and well-characterized
Cost-effective: Compared to prolonged testing or imaging, it's efficient
Established interpretation: Decades of data provide clear normal and abnormal thresholds

This contrasts with peptides still under investigation, where efficacy and safety profiles are still being defined across multiple clinical trials.

Accessing Cosyntropin

Because cosyntropin is FDA-approved, it's available by prescription through licensed pharmacies and administered in clinical settings (hospitals, endocrinology offices, outpatient diagnostic centers). It's not available over-the-counter and requires a physician's order for diagnostic testing.

Regional availability varies: it's widely available in the United States but may have restricted access in countries where regulatory approval hasn't been granted. If you believe you need adrenal function testing, consult an endocrinologist or your primary care physician to discuss whether the cosyntropin stimulation test is appropriate for your situation.

What is Cosyntropin? The Complete Guide to This FDA-Approved Peptide